The APIS MET Alterations Kit is a unique real-time PCR (RT-qPCR) assay simultaneously detecting both MET exon 14 skipping mutation (METΔex14) and MET gene overexpression, using RNA extracted from FFPE non-small cell lung cancer (NSCLC) tissue or blood plasma (cfRNA).
The APIS MET Alterations Kit is designed to detect the relative expression of the wild type cMET transcript, and the RNA product of mutations in MET that lead to the exon-skipping (deletion) of exon 14 (METΔex14 amplicon). A simple protocol compatible with most qPCR instruments. Kit size: 24 samples plus controls; 2x Primer Probe mixes, 2x Enzyme Mixes, Positive Control and No template control (NTC).
The APIS MET Alterations Kit is available as a Research Use Only (RUO) product. Not applicable for use in diagnostic procedures.
This product is manufactured in United Kingdom by APIS Assay Technologies.